Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Neurologic and cardiac rhythm abnormalities associated with 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) therapy.

× No keyword cloud information.

6 in total

1. Electrocardiogram abnormalities induced by amsacrine.

Authors: R B Weiss; D Moquin; J D Adams; J D Griffin; H Zimbler
Journal: Cancer Chemother Pharmacol Date: 1983 Impact factor: 3.333

Review 2. Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors: V B Pai; M C Nahata
Journal: Drug Saf Date: 2000-04 Impact factor: 5.606

Review 3. Myocardial diseases of animals.

Authors: J F Van Vleet; V J Ferrans
Journal: Am J Pathol Date: 1986-07 Impact factor: 4.307

4. Human tissue distribution of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141549, AMSA).

Authors: D J Stewart; G Zhengang; K Lu; N Savaraj; L G Feun; M Luna; R S Benjamin; M J Keating; T L Loo
Journal: Cancer Chemother Pharmacol Date: 1984 Impact factor: 3.333

5. Successful treatment of a patient with acute nonlymphoblastic leukemia (ANLL) and anthracycline cardiomyopathy with 4' (9-acridinylamino) methanesulfon-m-anisidide (AMSA).

Authors: M P Fanucchi; Z A Arlin
Journal: Cancer Chemother Pharmacol Date: 1982-12 Impact factor: 3.333

6. A phase II clinical study of mAMSA in small cell carcinoma of the lung.

Authors: P J Dady; A P Sappino; A Rudd; I E Smith
Journal: Cancer Chemother Pharmacol Date: 1981 Impact factor: 3.333

6 in total